Ankündigung

Einklappen
Keine Ankündigung bisher.

Vericel

Einklappen
X
  • Filter
  • Zeit
  • Anzeigen
Alles löschen
neue Beiträge

  • Vericel

    Vericel Corp Stock Skyrockets On Record 4Q Revenues

    Biopharmaceutical company Vericel Corp ([WIKI]NASDAQ[/WIKI]:VCEL) reported record revenues and improved net income for the 2017 fourth quarter and full year, sending shares rising nearly 8% in pre-market trading Monday.

    “We had record fourth quarter revenues and achieved both positive operating income and net income for the quarter, an important milestone for the company,” said Nick Colangelo, president and [WIKI]CEO[/WIKI] of Vericel. “Our record fourth quarter revenues represent the third straight quarter of 30% or higher revenue growth compared to the same quarter of the prior year, and this strong growth and margin expansion were driven by both the accelerating uptake of MACI as well as substantial growth for Epicel in the quarter.”

    Fourth Quarter 2017 Results

    Total net revenues for the quarter ended December 31, 2017 were $23.4 million, which included $16.1 million of MACI net revenue and $6.1 million of Epicel net revenue, compared to $12.8 million of Carticel® (autologous cultured chondrocytes) net revenue and $3.8 million of Epicel net revenue, respectively, in the fourth quarter of 2016. Total net revenues for the quarter ended December 31, 2017 also included $1.2 million in license revenue related to the company’s collaboration agreement with ICT. Total net revenues increased 41% compared to the fourth quarter of 2016, with MACI revenue increasing 26% and Epicel revenue increasing 62%, respectively, compared to the same period in 2016. Excluding license revenue, net revenues increased 34% compared to the fourth quarter of 2016.

    Gross profit for the quarter ended December 31, 2017 was $15.0 million, or 64% of net revenues, compared to $8.9 million, or 54 % of net revenues, for the fourth quarter of 2016.

    ...

    https://finance.yahoo.com/news/veric...132008041.html

    VCEL + 42%
    jetzt auf -> www.trading-stocks.de

    finviz Stock Screener

    Bitcoin Trading

  • #2
    AW: Vericel

    Vericel Reports Record Third Quarter Revenues of $22.5 Million and Raises Full Year 2018 Revenue Guidance

    Third Quarter 2018 Financial Highlights

    Total net revenues increased 58% to $22.5 million compared to $14.3 million in the third quarter of 2017;
    Gross margins of 64% compared to gross margins of 50% in the third quarter of 2017;
    Net loss of $1.1 million, or $0.02 loss per share, compared to net loss of $5.4 million, or $0.16 per share, in the third quarter of 2017;
    Non-GAAP adjusted EBITDA of $0.9 million compared to a loss of $2.9 million in the third quarter of 2017;
    As of September 30, 2018, the company had $97.8 million in cash and short-term investments compared to $26.9 million in cash at December 31, 2017; and
    Full year 2018 revenue guidance raised to $87 to $90 million compared to previous full year revenue guidance of $80 to $83 million.

    ...

    https://finance.yahoo.com/news/veric...123000391.html

    heute +46%

    jetzt auf -> www.trading-stocks.de

    finviz Stock Screener

    Bitcoin Trading

    Kommentar

    Lädt...
    X